Risk of Prosecution for Marijuana-Related Companies. If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution. The Department of Treasury recently issued guidance noting: “[T]he Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana. Many states impose and enforce similar prohibitions. Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”
Organigram Holdings Inc.: Q2 ’19
Included in this report:
• Cannin Tools
• Market & Industry Update
• Fundamental Analysis (Organigram Holdings Inc.)
• Medical Research
• Cannabis Terminology
• Hemp Infographic
• Industry Terminology
About Organigram Holdings Inc.
Organigram focuses on the high quality (award-winning), high-efficiency (as much as 400 grams per sf)) production of medical cannabis in New Brunswick, Canada. They are currently building high production cannabis facilities for adult use cannabis, expected fall 2018. The company claims New Brunswick offers low-cost advantages in electric power (base rate of 5.2 kWh), real estate and taxes (e.g. compared to Ontario).